Bio-Techne Corp (TECH)

Return on equity (ROE)

Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net income (ttm) US$ in thousands 73,400 131,666 158,137 150,712 168,105 203,001 224,160 246,700 285,262 271,302 261,823 291,991 272,051 225,487 210,530 176,631 140,411 184,298 174,948 248,296
Total stockholders’ equity US$ in thousands 1,918,810 2,018,020 2,078,490 2,138,650 2,068,850 2,014,380 1,963,560 1,997,750 1,966,520 1,889,690 1,827,110 1,751,150 1,701,010 1,713,320 1,702,530 1,646,960 1,571,230 1,547,940 1,530,850 1,439,280
ROE 3.83% 6.52% 7.61% 7.05% 8.13% 10.08% 11.42% 12.35% 14.51% 14.36% 14.33% 16.67% 15.99% 13.16% 12.37% 10.72% 8.94% 11.91% 11.43% 17.25%

June 30, 2025 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $73,400K ÷ $1,918,810K
= 3.83%

The analysis of Bio-Techne Corp’s return on equity (ROE) over the period from September 2020 to June 2025 reveals notable fluctuations with an overall declining trend. Starting at a high of 17.25% as of September 30, 2020, the ROE experienced a significant decrease by December 31, 2020, to 11.43%. This downward movement continued through the subsequent periods, reaching a low of 8.94% as of June 30, 2021. Brief periods of marginal recovery are observed, with ROE increasing to 10.72% by September 30, 2021, and stabilizing somewhat around the low teens, peaking at approximately 16.67% in September 2022. However, the general trajectory after this peak is downward, with the ROE declining to 14.33% in December 2022 and maintaining slight variations thereafter.

From the beginning of 2023 onward, the ROE continued to diminish, declining to 12.35% by September 2023, and further decreasing to 11.42% by the end of December 2023. The trend persists into 2024 and 2025, with the ROE falling below 10%, reaching 10.08% on March 31, 2024; 8.13% on June 30, 2024; and further down to 7.05% as of September 30, 2024. The decline extends through subsequent quarters, with the ROE at 7.61% on December 31, 2024, and dropping significantly to 6.52% by March 31, 2025. The lowest observed value within this period is 3.83% on June 30, 2025.

This pattern indicates a declining profitability or efficiency in utilizing shareholders’ equity over time, with some intermittent periods of stabilization. The substantial decrease in ROE towards the latter part of the analyzed period suggests potential challenges in maintaining prior levels of profitability, or possible changes in the company's operating environment, capital structure, or profit margins impacting overall return to shareholders.